Effects of a Supplement Enriched in Hydroxymethylbutyrate and Vitamin D on Muscle Strength in Hip Fracture
Launched by HOSPITAL CLINIC OF BARCELONA · May 7, 2013
Trial Information
Current as of May 06, 2025
Terminated
Keywords
ClinConnect Summary
Hip fractures are the cause of substantial morbidity and mortality in elderly people. Nine months after hip fracture, patients still have a poorer quality of life compared to control subjects matched for age and sex.
After a hip fracture, many patients fail to return to their homes and their previous state of mobility. Acute hospital costs generated by this condition are substantial, although the costs in rehabilitation and special care in long-term community are even greater.
Patients with hip fracture are most likely to be frail elderly, and they are usually malnourished when the fractu...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over 65 years of age after hip fracture surgery.
- • Ability to walk before fracture.
- Exclusion Criteria:
- • Chronic renal failure, defined as a glomerular filtration rate less than 60 mL/min/1.73 m2, or serum creatinine of 0.9 mg/dL in women or 1.2 mg/dL in men.
- • Following a diet with protein restriction.
- • Need for enteral or parenteral nutrition.
- • Need for medication with orexigenic or anabolic effect, or long-term corticosteroids.
- • Active neoplastic disease.
- • Cognitive impairment or major psychiatric disorder.
- • Lack of signed informed consent.
- • Any patient with inability to comply with treatment or not appropriate according to the investigator.
About Hospital Clinic Of Barcelona
The Hospital Clinic of Barcelona is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, the hospital integrates cutting-edge medical practices with rigorous scientific inquiry to enhance patient outcomes. As a prominent sponsor of clinical trials, the Hospital Clinic of Barcelona is dedicated to exploring new therapies and treatment modalities across various medical fields, fostering a culture of excellence in clinical research that ultimately aims to improve the quality of care for patients locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, Catalonia, Spain
Patients applied
Trial Officials
Maria T Forga, MD
Principal Investigator
Hospital Clinic of Barcelona
Joan Trabal, RD, MS
Study Chair
Hospital Clinic of Barcelona
Pere Leyes, MD
Study Chair
Hospital Clinic of Barcelona
Salvi Prat, MD, PhD
Study Chair
Hospital Clinic of Barcelona
Margarita Navarro, MD
Study Chair
Hospital Clinic of Barcelona
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials